Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studies how the public reacts to facial skin and hair conditions

Compares public reactions to facial psoriasis, eczema, vitiligo and alopecia areata in adults.

Plain-language title generated from the registry record
Registry title: Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Key facts

Where
Roma, ItalySee the site

Where in Italy

  • Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC DermatologiaRoma, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Trial code
NCT06801821
Record updated
26 August 2025
Original description
Primary objective:Read full original descriptionShow less

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

Primary objective:

The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata.

* Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.

Inclusion: -Patients aged>18 years, both sexes; Signature of written informed consent.

Exclusion: Those who for professional or personal reasons have direct knowledge of the diseases in question; Patients diagnosed with psoriasis, atopic dermatitis, vitiligo or alopecia areata; Patients with first-degree relatives with psoriasis, atopic dermatitis, vitiligo or alopecia areata.

ClinicalTrials.gov NCT06801821